From: Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study
Cross-over study arm | Total | ||
---|---|---|---|
Frovatriptan | Rizatriptan | ||
Active compounds | n (%) | n (%) | n (%) |
Ibuprofen | 25(23.2) | 23(24) | 48(23.5) |
Nimesulide | 21(19.4) | 15(15.6) | 36(17.7) |
Paracetamol/codeine | 13(12) | 8(8.3) | 21(10.3) |
Ketoprofen | 7(6.48) | 9(9.4) | 16(7.8) |
Diclofenac | 4(3.7) | 7(7.3) | 11(5.4) |
Indomethacin | 8(7.4) | 3(3.1) | 11(5.4) |
Naproxen | 7(6.5) | 3(3.1) | 10(4.9) |
Ketorolac | 5(4.6) | 4(4.2) | 9(4.4) |
Paracetamol | 5(4.6) | 2(2.1) | 7(3.4) |
Frovatriptan* | 1(0.9) | 6(6.3) | 7(2.5) |
Piroxicam | 3(2.8) | 2(2.1) | 5(2) |
Metamizol | 1(0.9) | 3(3.1) | 4(2) |
Metoclopramide | 1(0.9) | 3(3.1) | 4(1.5) |
Acetylsalicylic acid | 3(2.8) | 0 | 3(1) |
Eletriptan* | 1(0.9) | 2(2.1) | 3(0.5) |
Indomethacin/caffeine/prochlorperazine | 0 | 2(2.1) | 2(1) |
Almotriptan* | 1(0.9) | 1(1) | 2(3.4) |
Sumatriptan* | 0 | 2(2.1) | 2(1) |
Propiphenazon/butalbital/caffeine | 1(0.9) | 0 | 1(0.5) |
Rizatriptan* | 0 | 1(1) | 1(1.5) |
Betamethasone | 1(0.9) | 0 | 1(0.5) |
Total | 108 | 96 | 204 |